Provention Bio’s $2.9B Acquisition – A Strategic Fit For Sanofi
Sanofi SA (NASDAQ:SNY) has agreed to acquire Provention Bio Inc (NASDAQ:PRVB) for $25.00 per share in cash, representing an equity value of approximately…
Synchronoss Gets Takeover Offer From B. Riley At 44% Premium
Synchronoss Technologies, Inc (NASDAQ:SNCR) confirmed that on March 10, 2023, it received a non-binding proposal from B. Riley Financial, Inc (NASDAQ:RILY)…
JATT Acquisition Corp Announces Planned Transfer Of Listing To NASDAQ In Connection With Its Proposed Business Combination With Zura Bio Limited
JATT Acquisition Corp (NYSE:JATT, JATT.WS and JATT.U)))) (the "Company"), a publicly-traded special purpose acquisition company, today announced that it will voluntarily transfer the listing of its Class A
Seagen’s $43B Deal To Double Pfizer’s Early-Stage Oncology Pipeline, Seagen Says Is Right Step
Pfizer Inc (NYSE:PFE) has agreed to acquire Seagen Inc (NASDAQ:SGEN) for $229 in cash per Seagen share for a total enterprise value…
Synchronoss Technologies Confirms Receipt Of Non-Binding Proposal From B. Riley Financial To Acquire All Outstanding Shares Of The Company’s Common Stock For A Price Of $1.15 Per Share, Payable In Cash
Synchronoss Technologies Inc. ("Synchronoss" or the "Company") (NASDAQ:SNCR), a global leader and innovator in cloud, messaging, and digital products and platforms, today confirmed
Why Prevention Bio Stock Is Rocketing Past 52-Week Highs Today
Provention Bio Inc (NASDAQ: PRVB) shares are rocketing higher Monday after Sanofi (NASDAQ: SNY) announced plans to acquire the biopharmaceutical company.</
Installed Building Products Acquires Anchor Insulation, Adding $39M Of Annual Revenue
"With approximately $39 million of annual revenue, Anchor Insulation expands our presence to residential, commercial and industrial customers across the Northeastern United States," stated Jeff Edwards,
Pfizer Is Sending Seagen Stock Soaring Monday: What’s Going On?
Seagen Inc (NASDAQ: SGEN) shares are trading higher Monday after Pfizer Inc (NYSE: PFE) announced plans to acquire the global biotech company.